-
Pemetrexed: Reproducible Cell Assay Workflows
2026-08-20
Learn how Pemetrexed (SKU A4390) can support controlled cell viability, proliferation, and cytotoxicity studies through defined antifolate activity, documented solubility, and a practical in vitro concentration range. The article also explains assay design, interpretation, and vendor-selection considerations for cancer chemotherapy research.
-
DiscoveryProbe Natural Product Library Plus Guide
2026-08-19
The DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library for HTS and HCS workflows. Its pre-dissolved DMSO format and analytical quality controls support reproducible natural product screening for drug discovery, including mechanistic studies motivated by Cryptosporidium parvum AdhE inhibition.
-
Indole-3-pyruvic acid: Assay Workflows
2026-08-19
Indole-3-pyruvic acid supports both mechanistic plant hormone research and targeted immune-cell assays. This guide converts its TAA1 feedback biology and AhR-linked activity into practical workflows, controls, and troubleshooting strategies.
-
Triazole ALDH2 Activators for Myocardial Ischemia
2026-08-18
This 2025 ACS Medicinal Chemistry Letters study used molecular simulation and structure-guided optimization to develop triazole aldehyde dehydrogenase 2 activators with improved activity and water solubility. Representative compound Z17 produced strong ALDH2 activation and improved cardiac and biochemical outcomes in a mouse myocardial ischemia–reperfusion model, while important translational limitations remain.
-
Nicotinamide Riboside Chloride in RGC Research
2026-08-18
Nicotinamide Riboside Chloride (NIAGEN) adds a controllable NAD+ metabolism variable to chemically defined retinal ganglion cell workflows. Used alongside dual SMAD and Wnt inhibition, it helps researchers distinguish lineage-generation effects from energy-homeostasis effects in metabolic and neurodegenerative disease models.
-
Cy3 NHS ester (non-sulfonated) Workflow Guide
2026-08-17
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent handle for amino-group labeling of proteins, peptides, and amine-modified oligonucleotides or DNA. It is appropriate when a workflow can tolerate DMSO or DMF, but it should not be treated as a water-soluble reagent or used for direct aqueous labeling of solvent-sensitive biomolecules.
-
Latrunculin B: Reading Actin Perturbation
2026-08-17
Latrunculin B is more than an actin polymerization inhibitor: its transient, serum-sensitive behavior can sharpen interpretation of cytoskeletal and viral-entry assays. This guide connects molecular mechanism with the inhibitor-comparison strategy used in GCRV research.
-
Dynasore: Practical Endocytosis Workflow Guide
2026-08-16
Dynasore is a cell-permeable dynamin GTPase inhibitor for experimentally perturbing dynamin-dependent endocytosis, vesicle trafficking, and related cellular readouts. It is appropriate for controlled in vitro and cellular studies, but should not be treated as a universal dynamin-specific probe or as evidence for clinical efficacy.
-
Sulfo-NHS-Biotin for Single-Cell Assays
2026-08-15
Sulfo-NHS-Biotin converts primary-amine chemistry into a practical biotin handle for protein capture, cell-surface profiling, and modular single-cell assays. This guide translates nanovial-based functional screening into an actionable labeling workflow, with parameter choices and troubleshooting advice for preserving antigen activity and cell viability.
-
Optimizing Calcium Phosphate Transfection
2026-08-14
A 2026 study identifies the DNA concentration-to-reaction-volume balance as the main determinant of calcium phosphate transfection performance in HEK293T cells. Its optimized condition, 80 μg plasmid DNA in 1 mL for 2–3 × 10⁵ cells/mL, provides a practical starting point for improving an economical nonviral delivery method.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-08-14
Borchert et al. linked homologous recombination repair defects, including BAP1-associated BRCAness, with olaparib sensitivity in malignant pleural mesothelioma models. Their combination of cell-line pharmacology and gene-expression profiling suggests a route toward biomarker-guided PARP inhibition, while also clarifying why in vitro findings should not yet be treated as clinical treatment evidence.
-
Cisapride: A Mechanistic Anchor for Cardiac Screens
2026-08-13
Cisapride (R 51619) can serve as a mechanistically informative challenge compound for cardiac electrophysiology research, linking 5-HT4 signaling with hERG channel inhibition. This guide explains how to use it in iPSC-cardiomyocyte phenotypic screens without confusing receptor-driven beat changes with direct repolarization liability.
-
MALAT1–miR-125b–STAT3 Axis in Sepsis
2026-08-13
The reference study links the lncRNA MALAT1 to increased procalcitonin expression in sepsis through a miR-125b/STAT3 regulatory axis. By combining patient samples, an LPS-stimulated U937 model, RNA interaction assays, and rescue experiments, it provides a mechanistic framework for interpreting PCT regulation while also highlighting limitations that require validation in primary cells and clinical cohorts.
-
Diethylmaleate for Reliable Redox Assays
2026-08-12
This scenario-driven guide explains how Diethylmaleate supports reproducible glutathione-depletion, oxidative-stress, viability, and cytotoxicity workflows. It provides practical selection and handling guidance for SKU B6151, while distinguishing literature-backed findings from assay-development recommendations.
-
Bradykinin (BA5201): Practical Assay Workflow
2026-08-12
Bradykinin (BA5201) provides a defined research peptide input for controlled studies of endothelial vasodilation, vascular permeability modulation, smooth muscle contraction, pain mechanisms, and inflammation signaling. It should be handled as a freshly prepared research reagent, not as a long-term solution, diagnostic material, or medical product.